Time for dividend reinvestment and this time I decided to add on existing AbbVie position and bought additional 10 shares for 143,93 USD per share. Abbvie has it’s risks with outgoing blockbusters but overall I consider the company solid and valuation decent. This is part of attempt to increase overall exposure on medical and pharmaceuticals. Assuming that market does not move from recession mode to bull market anytime soon, I’ll probably try to add on Pfizer and Johnson & Johnson during the next three quarters. Johnson & Johnson is bit of a question mark with the consumer spinoff and all. Anyway this will happen with dividend reinvestments only as I haven’t felt comfortable changing euros to dollars in a long long time. Quite contrary, I’m tempted to start converting received dividends back to euros or possibly to swedish kronas. That would make sense but then again majority of interesting companies are dollar nominated.